Coldstream Capital Management Inc Kymera Therapeutics, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KYMR
# of Institutions
186Shares Held
66.9MCall Options Held
73.4KPut Options Held
13K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$225 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$217 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$201 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$201 Million2.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$176 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.84B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...